Oppenheimer & Co. Inc. Has $1.13 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Oppenheimer & Co. Inc. decreased its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,548 shares of the company's stock after selling 11,555 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in DocuSign were worth $1,129,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the business. Oppenheimer Asset Management Inc. grew its position in DocuSign by 64.9% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 8,976 shares of the company's stock worth $807,000 after buying an additional 3,534 shares during the last quarter. Kovack Advisors Inc. acquired a new stake in DocuSign during the 4th quarter worth about $207,000. FUKOKU MUTUAL LIFE INSURANCE Co purchased a new position in shares of DocuSign in the fourth quarter worth approximately $234,000. Mn Services Vermogensbeheer B.V. raised its holdings in shares of DocuSign by 2.1% during the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 82,100 shares of the company's stock valued at $7,384,000 after acquiring an additional 1,700 shares during the period. Finally, K.J. Harrison & Partners Inc purchased a new stake in shares of DocuSign in the 4th quarter valued at approximately $271,000. 77.64% of the stock is owned by institutional investors and hedge funds.

DocuSign Trading Down 4.2 %

DOCU stock traded down $3.44 during trading on Thursday, reaching $78.92. 1,472,475 shares of the stock were exchanged, compared to its average volume of 2,008,068. The stock has a 50 day simple moving average of $89.64 and a 200-day simple moving average of $78.28. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The company has a market capitalization of $15.94 billion, a P/E ratio of 16.31, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Jefferies Financial Group raised their target price on DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. HSBC reiterated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. UBS Group boosted their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a report on Friday, December 6th. Finally, Robert W. Baird lifted their target price on shares of DocuSign from $59.00 to $100.00 and gave the company a "neutral" rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $92.45.

Insider Buying and Selling at DocuSign

In related news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now directly owns 156,050 shares of the company's stock, valued at $14,050,742. This trade represents a 20.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the company's stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the sale, the director now directly owns 906,430 shares in the company, valued at $87,959,967.20. This represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 686,010 shares of company stock valued at $66,102,694 in the last 90 days. 1.66% of the stock is currently owned by company insiders.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.